CDSCO Panel Grants Roche’s Protocol Amendment Proposal For Crovalimab study
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Roche’s protocol amendment proposal for the clinical trial titled “A study evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of crovalimab in pediatric participants with the atypical hemolytic uremic syndrome (aHUS) (COMMUTE-p)”. This came after […]